Immunoadjuvant Therapy and Noninvasive Ventilation for Acute Respiratory Failure in Lung Tuberculosis: A Case Study

Figure 2

Changes in SatO2 and PaCO2 and respiratory rate (RR) in relation to the application of noninvasive pressure support ventilation (NIPSV) and 3 doses of etanercept 25 mg administered subcutaneously (black arrowheads).